Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survival

Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survival

Abstract Background To evaluate the impact of radiation dose on overall survival (OS) in patients treated with adjuvant chemoradiation (CRT) for pancreatic ductal adenocarcinoma (PDAC). Methods A multicenter retrospective analysis on 514 patients with PDAC (T1–4; N0–1; M0) treated with surgical rese...

Full description

Bibliographic Details
Main Authors: Alessio G. Morganti, Francesco Cellini, Milly Buwenge, Alessandra Arcelli, Sergio Alfieri, Felipe A. Calvo, Riccardo Casadei, Savino Cilla, Francesco Deodato, Giancarmine Di Gioia, Mariacristina Di Marco, Lorenzo Fuccio, Federica Bertini, Alessandra Guido, Joseph M. Herman, Gabriella Macchia, Bert W. Maidment, Robert C. Miller, Francesco Minni, Paolo Passoni, Chiara Valentini, Alessia Re, William F. Regine, Michele Reni, Massimo Falconi, Vincenzo Valentini, Gian Carlo Mattiucci
Format: Article
Language:English
Published: BMC 2019-06-01
Series:BMC Cancer
Subjects:
Pancreatic neoplasm
Radiotherapy
Adjuvant
Dose effect
Online Access:http://link.springer.com/article/10.1186/s12885-019-5790-2

Internet

http://link.springer.com/article/10.1186/s12885-019-5790-2

Similar Items